These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1360812)

  • 1. Smoking and schizophrenia.
    Lohr JB; Flynn K
    Schizophr Res; 1992 Dec; 8(2):93-102. PubMed ID: 1360812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature.
    Dalack GW; Meador-Woodruff JH
    Schizophr Res; 1996 Nov; 22(2):133-41. PubMed ID: 8958597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    Kerwin RW
    Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine dependence and schizophrenia.
    Ziedonis DM; Kosten TR; Glazer WM; Frances RJ
    Hosp Community Psychiatry; 1994 Mar; 45(3):204-6. PubMed ID: 7910577
    [No Abstract]   [Full Text] [Related]  

  • 8. Smoking and schizophrenia.
    Sagud M; Mihaljević-Peles A; Mück-Seler D; Pivac N; Vuksan-Cusa B; Brataljenović T; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):371-5. PubMed ID: 19794359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
    Dursun SM; Kutcher S
    Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
    Brown KW; White T; Palmer D
    Psychol Med; 1992 Feb; 22(1):69-77. PubMed ID: 1349440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where there's smoke ... nicotine and psychiatric disorders.
    Kirch DG
    Biol Psychiatry; 1991 Jul; 30(2):107-8. PubMed ID: 1912102
    [No Abstract]   [Full Text] [Related]  

  • 13. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of outcome in first-episode schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1993 Mar; 54 Suppl():13-7. PubMed ID: 8097192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW; White T
    Biol Psychiatry; 1991 Dec; 30(12):1182-90. PubMed ID: 1686411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on "tardive dyskinesia circa 2006".
    Rosenheck RA
    Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
    [No Abstract]   [Full Text] [Related]  

  • 19. Smoking and movement disorders in psychiatric patients.
    Menza MA; Grossman N; Van Horn M; Cody R; Forman N
    Biol Psychiatry; 1991 Jul; 30(2):109-15. PubMed ID: 1680470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL
    Adv Neurol; 1995; 65():211-29. PubMed ID: 7872142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.